Evidence map›Paper›PMID 31570576›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2019

IL-2 receptors preassemble and signal in the ER/Golgi causing resistance to antiproliferative anti-IL-2Rα therapies.

Julianna Volkó, Ádám Kenesei, Meili Zhang, Péter Várnai, Gábor Mocsár, Michael N Petrus, Károly Jambrovics, Zoltán Balajthy, Gabriele Müller, Andrea Bodnár and 3 more

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Significance of Receptor Mobility in Multivalent Binding on Lipid Membranes.Angewandte Chemie (International ed. in English) · 2022
    Review
  12. Article
  13. IL-15Journal of immunology (Baltimore, Md. : 1950) · 2021
    Article
  14. Optimal ligand discrimination by asymmetric dimerization and turnover of interferon receptors.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  15. Cytokine receptor cluster size impacts its endocytosis and signaling.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  16. Article
  17. Article
  18. Article
  19. Observational
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 3 countries.

Julianna VolkóDepartment of Biophysics and Cell Biology, Doctoral School of Molecular Medicine, Faculty of Medicine, University of Debrecen, H-4032 Debrecen, Hungary.
Ádám KeneseiDepartment of Biophysics and Cell Biology, Doctoral School of Molecular Medicine, Faculty of Medicine, University of Debrecen, H-4032 Debrecen, Hungary.
Meili ZhangLymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892.
Péter VárnaiDepartment of Physiology, Faculty of Medicine, Semmelweis University, H-1094 Budapest, Hungary.
Gábor MocsárDepartment of Biophysics and Cell Biology, Doctoral School of Molecular Medicine, Faculty of Medicine, University of Debrecen, H-4032 Debrecen, Hungary.
Michael N PetrusLymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892.
Károly JambrovicsDepartment of Biochemistry and Molecular Biology, Doctoral School of Molecular Cellular and Immune Biology, Faculty of Medicine, University of Debrecen, H-4032 Debrecen, Hungary.
Zoltán BalajthyDepartment of Biochemistry and Molecular Biology, Doctoral School of Molecular Cellular and Immune Biology, Faculty of Medicine, University of Debrecen, H-4032 Debrecen, Hungary.
Gabriele MüllerDivision of Biophysics of Macromolecules, German Cancer Research Center, D-69120 Heidelberg, Germany.
Andrea BodnárDepartment of Biophysics and Cell Biology, Doctoral School of Molecular Medicine, Faculty of Medicine, University of Debrecen, H-4032 Debrecen, Hungary.
Katalin TóthDivision of Biophysics of Macromolecules, German Cancer Research Center, D-69120 Heidelberg, Germany.
Thomas A WaldmannLymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892; tawald@helix.nih.gov vamosig@med.unideb.hu.
György VámosiDepartment of Biophysics and Cell Biology, Doctoral School of Molecular Medicine, Faculty of Medicine, University of Debrecen, H-4032 Debrecen, Hungary; tawald@helix.nih.gov vamosig@med.unideb.hu.ORCID 0000-0002-7940-2787
University of Debrecen · HUNational Cancer Institute · USGerman Cancer Research Center · DESemmelweis University · HU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Interleukin-2 (IL-2) and IL-15 play pivotal roles in T cell activation, apoptosis, and survival, and are implicated in leukemias and autoimmune diseases. Their heterotrimeric receptors share their β- and γ

Indexed as

Cell Line, TumorCell ProliferationEndoplasmic ReticulumGolgi ApparatusHeLa CellsHumansInterleukin-15Interleukin-2Interleukin-2 Receptor alpha SubunitJanus Kinase 1Janus Kinase 3Receptors, Interleukin-15Signal TransductionInterleukin-15Interleukin-2Interleukin-2 Receptor alpha SubunitJanus Kinase 1Janus Kinase 3Receptors, Interleukin-15adult T cell leukemia/lymphomaantiproliferative antibody therapyautocrine signalingFörster resonance energy transferIL-2/15 receptor preassembly

Identifiers

PMID31570576
PMCPMC6800387
OpenAlexW2978801752

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.